Total Valuation
Surgical Science Sweden AB has a market cap or net worth of $267.26M. The enterprise value is $964.04.
Market Cap$267.26M
Enterprise Value$964.04
Share Statistics
Surgical Science Sweden AB has 51,026,237 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding51,026,237
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Surgical Science Sweden AB’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.64%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)1.64%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee3.11M
Profits Per Employee209.46K
Employee Count319
Asset Turnover0.21
Inventory Turnover2.02
Valuation Ratios
The current PE Ratio of Surgical Science Sweden AB is 27.8. Surgical Science Sweden AB’s PEG ratio is -0.50.
PE Ratio27.8
PS Ratio1.67
PB Ratio0.39
Price to Fair Value0.39
Price to FCF24.35
Price to Operating Cash Flow17.42
PEG Ratio-0.50
Income Statement
In the last 12 months, Surgical Science Sweden AB had revenue of 992.34M and earned 66.82M in profits. Earnings per share was 1.31.
Revenue992.34M
Gross Profit576.90M
Operating Income108.97M
Pretax Income100.14M
Net Income66.82M
EBITDA192.34M
Earnings Per Share (EPS)1.31
Cash Flow
In the last 12 months, operating cash flow was 149.13M and capital expenditures -43.08M, giving a free cash flow of 106.05M billion.
Operating Cash Flow149.13M
Free Cash Flow106.05M
Free Cash Flow per Share2.08
Dividends & Yields
Surgical Science Sweden AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.23
52-Week Price Change-47.24%
50-Day Moving Average3.69
200-Day Moving Average3.53
Relative Strength Index (RSI)84.36
Average Volume (3m)40.00
Important Dates
Surgical Science Sweden AB upcoming earnings date is Nov 12, 2026, TBA (Confirmed).
Last Earnings DateAug 19, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Surgical Science Sweden AB as a current ratio of 4.07, with Debt / Equity ratio of 0.06%
Current Ratio4.07
Quick Ratio3.36
Debt to Market Cap0.01
Net Debt to EBITDA-2.79
Interest Coverage Ratio17.34
Taxes
In the past 12 months, Surgical Science Sweden AB has paid 33.32M in taxes.
Income Tax33.32M
Effective Tax Rate0.33
Enterprise Valuation
Surgical Science Sweden AB EV to EBITDA ratio is 5.83, with an EV/FCF ratio of 16.45.
EV to Sales1.13
EV to EBITDA5.83
EV to Free Cash Flow16.45
EV to Operating Cash Flow14.05
Balance Sheet
Surgical Science Sweden AB has $658.39M in cash and marketable securities with $2.86M in debt, giving a net cash position of $655.53M billion.
Cash & Marketable Securities$658.39M
Total Debt$2.86M
Net Cash$655.53M
Net Cash Per Share$12.85
Tangible Book Value Per Share$17.11
Margins
Gross margin is 62.24%, with operating margin of 10.98%, and net profit margin of 6.73%.
Gross Margin62.24%
Operating Margin10.98%
Pretax Margin10.09%
Net Profit Margin6.73%
EBITDA Margin19.38%
EBIT Margin10.98%
Analyst Forecast
The average price target for Surgical Science Sweden AB is $4.69, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.69
Price Target Upside-13.22% Downside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast20.42%
EPS Growth Forecast16.64%